Chelsea is paying it forward for cancer research

Chelsea Stutchbury’s stirring debut single has been launched worldwide with 100 per cent of proceeds donated to cancer research.

Chelsea, a cancer survivor, battled life-threatening lymphoma to fulfill her dream to sing.

Her incredible journey has led to encounters with Katy Perry, Delta Goodrem and Taylor Swift, which fuelled her musical ambition.

The 18-year-old Queensland Conservatorium student from central Queensland’s Coral Coast named the song Vincristine – after a chemotherapy chemical she required.

Chelsea said proceeds from her song would be donated to QIMR Berghofer Medical Research Institute.

A chance conversation with the Institute’s Professor Geoff Hill, when he filled in for her regular specialist, led her to that decision.

“He mentioned they always need money for research,” she said.

“Mum and I thought it would be lovely to be able to give back to his life-saving work.

“If it were not for research I would not be here – it is close to my heart.”

QIMR Berghofer Senior Scientist and former Queenslander of the Year Professor Geoff Hill said the funds raised would help continue vital and promising cancer research.

“Breakthrough technology, which involves manipulating the immune system, is increasingly effective in treating cancer. But it is expensive and difficult to fund in clinical practice,” Professor Hill said.

“Additional funds like these will help to ensure that we do not fall behind the rest of the world in this area.”

Chelsea said the song would not have been possible without the support of Dr James Morton, Nick Adams, Make a Wish and Sony Foundation Australia.

Vincristine is available on iTunes and Spotify.